Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Expect Bayer To Get Heat At FDA Advisory Panel Over Essure Adverse Events, Doc Training

This article was originally published in The Gray Sheet

Executive Summary

FDA’s Obstetrics and Gynecology Devices Advisory Panel will discuss risk mitigation for pain, bleeding, and other events associated with its Essure sterility device on Sept. 24. Meanwhile, Bayer’s new summary for the meeting reveals several lawsuits were filed against it “making allegations [on] clinical trials and safety,” of Essure. A Citizen Petition says altered trial patient records and violations of adverse event reporting rules by Conceptus in 2011 invalidates its PMA.

Advertisement

Related Content

US FDA's Gottlieb Wants Safety Built Into New Medtech Products, But Budget Will Be Cut To Surveil Older Ones
FDA Says Bayer's Response To Essure Investigation Satisfactory; Approves Product Label
FDA Investigating Attorney, Physician Beefs With Bayer’s Essure PMA
Essure Panel Stresses Need For Patient Follow-Up, But Stressed-Out Patients Say, ‘Recall It’
Bayer Buys Essure Contraceptive-Maker Conceptus For $1.1 Billion
Conceptus Essure Contraceptive Approved Three Months Post-Panel Review
Conceptus Essure Contraceptive Could Go To Panel As Early As July

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT034239

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel